Jardine Matheson half-year results 2026: cash flow and dividend rise as portfolio overhaul gathers pace

Jardine Matheson’s first-half results at a glance

Jardine Matheson Holdings Ltd delivered a positive first half of 2026, with stronger adjusted earnings, improved parent-company cash generation and an 8% dividend increase.

The wider story is strategic. Jardine Matheson is attempting to evolve from a complicated conglomerate into a more focused investment company, actively selling weaker or non-core holdings and redeploying capital into businesses offering better returns.

That transition appears to be moving forward, although investors still have reasons to remain watchful. Group revenue declined, Astra encountered difficult conditions in Indonesia and Jardine Matheson’s five-year total shareholder return remains well below its newly announced 2030 target.

The full original company announcement provides the detailed financial statements.

Key figure	H1 2026	Change
Adjusted underlying net profit	US$735 million	Up 9%
Reported net profit	US$542 million	Up 3%
Parent free cash flow	US$709 million	Up 21%
Revenue	US$15.9 billion	Down 7%
Interim dividend per share	US$0.65	Up 8%
Parent net cash	US$379 million	Up from US$41 million
Five-year annualised total shareholder return	4.4%	Down 3.1 percentage points

Adjusted profit grew, but the comparison needs explaining

Adjusted underlying net profit increased by 9% to US$735 million. This measure adjusts the prior period for business disposals and the accounting reclassification of Zhongsheng from an associate to an investment.

On the reported underlying basis, profit attributable to shareholders was US$738 million, down 3% from US$764 million. The adjusted figure is therefore the more favourable comparison, but management has provided a reasonable explanation for why it believes this better reflects the continuing portfolio.

Higher contributions from Jardine Pacific, Hongkong Land and DFI Retail, alongside lower financing costs, outweighed weakness in Astra’s Mining Solutions and Heavy Equipment business.

There was also a US$24 million non-recurring benefit from lease remeasurement within Jardine Pacific’s motor retail business. Investors should bear that one-off contribution in mind when assessing the quality of the profit increase.

Reported net profit rose by 3% to US$542 million. Fair-value losses on other investments, primarily Zhongsheng, were partly offset by valuation gains on Hongkong Land’s Central Portfolio.

Cash flow supports a higher dividend and further investment

The strongest part of the results was arguably the parent company’s cash generation.

Jardine Matheson parent free cash flow increased by 21% to US$709 million. The company defines this as recurring dividend income received from portfolio businesses, less corporate costs and net financing charges.

Parent net cash reached US$379 million at 30 June 2026, compared with US$41 million at the end of 2025. This provides financial flexibility ahead of the I-MED Radiology Network acquisition and the recently launched share buyback.

The interim dividend increased by 8% to US$0.65 per share. It is due to be paid on 14 October 2026 to shareholders on the register at the close of business on 21 August 2026, with a scrip alternative available.

Management also upgraded full-year dividend guidance. It now expects to pay at least US$2.47 per share for 2026, representing growth of at least 5%.

The portfolio reshaping is becoming more visible

Jardine Matheson recycled US$1.49 billion of capital during the first half, broadly similar to US$1.56 billion a year earlier. This included sales of non-control holdings and assets considered unlikely to meet the group’s return requirements.

Transactions included Jardine Cycle & Carriage’s sale of a US$188 million Vinamilk stake and a US$146 million Toyota Motor Corporation stake. Jardine Matheson also reduced its position in Zhongsheng.

Across the group, investments and commitments reached US$3.2 billion. The largest announced transaction was the US$2.4 billion acquisition of Australian healthcare business I-MED Radiology Network, which is expected to complete in the fourth quarter of 2026.

Jardine Matheson also completed the US$250 million buyback announced in November 2025 and initiated a further US$500 million programme running to the end of 2027.

These moves fit the commitments announced at June’s Investor Day:

• Deliver a five-year total shareholder return of at least 9% per year.
• Grow the dividend by at least 5% annually through 2030.
• Recycle at least US$4 billion of capital.
• Generate at least US$200 million of underlying net profit from new growth pillars.

Total shareholder return, or TSR, combines share-price performance and dividends. Jardine Matheson’s annualised five-year TSR currently stands at 4.4%, so reaching the new target will require a meaningful improvement.

Mixed performance across the portfolio

Astra remains the biggest pressure point

Astra remained Jardine Matheson’s largest underlying profit contributor, but its contribution fell by 8% to US$358 million.

Astra’s rupiah-denominated net profit excluding non-recurring items declined by 7% to IDR14.9 trillion. In US dollar terms, profit fell by 12% because of the weaker rupiah.

Higher profits from Automotive, Financial Services and other activities were outweighed by weaker Mining Solutions and Heavy Equipment earnings. The temporary stoppage at the Martabe gold mine also affected performance, although operations resumed during the second quarter.

Management expects Indonesia’s operating environment to remain challenging during the rest of 2026, while anticipating modest macroeconomic improvement and a stronger second-half contribution from mining-related activities.

Hongkong Land and DFI Retail moved forward

Hongkong Land’s contribution increased by 14% to US$140 million, helped by lower financing charges. It has now generated US$3.7 billion of net proceeds under its capital recycling plan, representing 93% of its US$4 billion target for the end of 2027.

DFI Retail’s contribution rose by 11% to US$90 million, supported by improved operating profit and lower financing costs. It also increased its interim dividend and upgraded its own full-year profit guidance.

Jardine Pacific contributed US$102 million, up US$35 million, although the improvement included the US$24 million lease remeasurement gain.

Mandarin Oriental and Jardine Cycle & Carriage recorded lower contributions. Mandarin Oriental was fully privatised in January after Jardine Matheson acquired the remaining 11.96% it did not already own.

What investors should watch in the second half

Full-year earnings guidance remains unchanged. Management expects profit to be in line with 2025 after adjusting for disposals and the reclassification of Zhongsheng.

The cash flow, stronger parent balance sheet and higher dividend are encouraging. Portfolio simplification is also moving beyond promises, with disposals, buybacks and a sizeable new healthcare investment all under way.

The main risks are execution and portfolio quality. Revenue fell by 7% to US$15.9 billion, Astra remains exposed to economic and currency weakness in Indonesia, and the US$2.4 billion I-MED deal must still complete and be integrated successfully.

For now, Jardine Matheson has shown that it can generate cash while reshaping the group. The next test is whether this activity translates into sustainably stronger returns and closes the gap between its current 4.4% five-year annualised TSR and the target of at least 9%.